Animal Therapeutics and Diagnostics

SUMMARY

This report:

• Makes a thorough evaluation of the animal therapeutic and diagnostic markets, including vaccines, pharmaceuticals, feed additives and diagnostics
• Covers worldwide markets, with special emphasis on U.S. trends and statistics
• Provides detailed information based on product categories, product use, forecasts and competitive analyses for each segment
• Determines the current market status and makes projections over a five-year period from 2008 to 2013.

INTRODUCTION

Study Goals and Objectives

This BCC Research report, Animal Therapeutics and Diagnostics, provides an overview of products included in this market, and detailed market analyses and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the animal therapeutic and diagnostic market.

Reasons for doing the study

The animal health industry is responsible for maintaining the health and productivity of the over 3.3 billion livestock and 16 billion poultry worldwide, and ensuring the wholesomeness and abundance of the food they produce. In addition, the industry must also cater to the health and well being of companion animals. Despite this, the human healthcare market is 35 times larger than the combined market for all nonhuman species. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates, and being the first to market. Despite all these risks, the industry continues to grow.

In contrast to human blockbuster-oriented pharmaceuticals, animal health is dominated by large numbers of products with small revenues. Although there are hundreds of products involved in this market, only about 20 products have sales exceeding $100 million per year. However, the industry continues to forge on. The fastest growing therapeutic categories are in the area of companion animals, specifically in the arthritis and pain segments of the market.

A challenging aspect of the market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Consumers are becoming more health conscious and demanding healthy and balanced diets. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment as animals produce minimal amounts of manure.

Intended Audience

The information within this report is directed at the business and industry professional and is specifically designed to aid in the explanation, direction, and future of animal health markets. The report focuses on providing the reader with an understanding of trends in the industry, market segments, market forecasts, leading players, market drivers and inhibitors.

Scope of Report

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutic and diagnostic market. The geographical scope of this study is worldwide, with special interest in U.S. trends and statistics. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics includes products that are used at the point of care and are considered rapid tests or kits. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.

Information Sources

The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 50 key executives, product managers, and clinical specialists involved in the animal health industry. Secondary methods included published literature in the area of animal science and veterinary services, investment reports, company literature, and various animal health journals.

All market data pertains to the global market at the manufacturers' level. Data is expressed in current U.S. dollars. The base year of the report is 2007, with historical data provided for 2006, and forecast data provided for 2008 and 2013. Historical, base year and forecast data is provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2007 base year.

Although this study provides information on a variety of products used to treat animals, it does not include a comprehensive list of all products available.

TABLE OF CONTENTS

• Animal Therapeutics and Diagnostics

Chapter- 1: SUMMARY

• SUMMARY TABLE TOTAL ANIMAL THERAPEUTIC AND DIAGNOSTIC MARKET BY MAJOR SEGMENT, THROUGH 2013 ($ MILLIONS)
• SUMMARY FIGURE TOTAL ANIMAL THERAPEUTIC AND DIAGNOSTIC MARKET BY MAJOR SEGMENT, 2006-2013 ($ MILLIONS)
• LEADING PRODUCTS AND MANUFACTURERS

Chapter- 2: INDUSTRY OVERVIEW

• ANIMAL ANATOMY AND PHYSIOLOGY
• ANIMAL ANATOMY AND PHYSIOLOGY (CONTINUED)
• REPRODUCTIVE SYSTEM
  • TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES
• AVIAN ANATOMY
• Avian Anatomy (Continued)
• Avian Anatomy (Continued)
• ANIMAL POPULATIONS
• COMPANION ANIMALS
  • TABLE 2 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2007, UNITED STATES (THOUSANDS)
• FARM ANIMALS
  • TABLE 3 REPORTED 2005 AND ESTIMATED 2006* POPULATION OF FARM ANIMALS, UNITED STATES (MILLIONS)
  • TABLE 4 LIFESPAN OF COMMON PET AVIAN SPECIES
  • TABLE 4 (CONTINUED)
• COMPANION ANIMAL DISEASES
• INFECTIOUS DISEASES
• Viruses
• Adenovirus
• Avian Influenza
• Coronavirus
• Distemper
• Eastern Equine Encephalitis
• Equine Viral Arteritis
• Feline Calicivirus and Feline Herpes Virus
• Feline Immunosuppressive Virus
• Feline Infectious Peritonitis Virus
• Feline Leukemia Virus
• Infectious Hepatitis
• Internal Papillomatosis of Parrots
• Newcastle Disease
• Pacheco's Disease
• Parainfluenza Virus
• Paramyxoviruses
• Parvovirus
• Polyomavirus
• Poxviruses
• Psittacine Beak and Feather Disease
• Rabies
• Reovirus
• West Nile Virus
• Bacteria
• Black Tongue
• Bordetella
• Brucellosis
• Campylobacteriosis
• Chlamydia
• Leptospirosis
• Lyme Disease
• Q-Fever
• Respiratory Mycoplasmosis
• Spirochaetaceae
• Tetanus
• ALLERGY AND INFLAMMATORY DISEASES
• Allergies
• Arthritis
• Asthma
• Dermatitis
• Eosinophilic Granuloma Complex
• Gout
• Inflammatory Bowel Disease
• METABOLIC DISEASES
• Cushing's Syndrome
• Diabetes Mellitus
• Thyroid Disease
• Pancreatitis
• Metabolic Bone Disease in Birds
• PARASITIC DISEASES
• Ear Mites
• Fleas
• Heartworm
• Hemobartonellosis
• Feline Scabies
• Lice
• Sarcoptic Mange
• Worms
• Urinary Diseases
• Glomerulonephritis
• Feline Lower Urinary Tract Disease
• Other Diseases
• Equine Protozoal Myelitis
• Leptospirosis and Equine Recurrent Uveitis
• Neoplastic Disease
• Neoplastic Disease (Continued)
• Heart Disease
• FOOD ANIMAL DISEASES
• INFECTIOUS DISEASES
• Viruses and Prions
• Avian Pneumovirus
• Bovine Spongiform Encephalopathy
• Bovine Viral Diarrhea
• Bovine Viral Diarrhea (Continued)
• Classical Swine Fever
• Foot and Mouth Disease
• Furunculosis
• Infectious Pancreatic Necrosis
• Marek's Disease
• Pathogenic Avian Influenza
• Q-Fever
• Vesicular Stomatitis
• Bacteria
• Anthrax
• Blackleg
• Conjunctivitis
• Tetanus
• OTHER DISEASES OF FOOD ANIMALS
• Heartwater
• Pneumonia
• Texas Cattle Fever
• ZOONOTIC DISEASES
• ZOONOTIC DISEASES (CONTINUED)
  • TABLE 5 COMMON EXAMPLES OF ZOONOTIC DISEASES
• ISSUES AFFECTING THE MARKET
• ANTIBIOTIC USE AND RESISTANCE IN FOOD ANIMALS
• Therapeutic Use
  • TABLE 6 APPROVED ANTIBIOTICS AND SULFONAMIDES USED IN DIARY AND BEEF CATTLE PRODUCTION IN U.S.
  • TABLE 7 APPROVED ANTIBIOTICS USED IN HOG PRODUCTION IN U.S.
  • TABLE 8 APPROVED ANTIBIOTICS USED IN SHEEP PRODUCTION IN U.S.
  • TABLE 9 APPROVED ANTIBIOTICS USED IN CHICKEN AND TURKEY PRODUCTION IN U.S.
• Resistance
• Human Side-Effects
• Microbial Ecology
• PROBIOTICS
• LEGAL AND REGULATORY ISSUES
• Minimally and Highly Regulated Products
• Animal Drug User Fee Act of 2003
• ANIMAL HEALTH INSURANCE
• Animal Health Insurance (Continued)
• SPRAY-ON DRUGS
• BIOTECHNOLOGY
• ANIMAL OBESITY
• Causes
• Weight Reduction
• NEW TRENDS IN AGING DISEASES
• COMPANION PET OWNERSHIP
• DEMAND IN THE VETERINARY SERVICE INDUSTRY
  • TABLE 10 ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN THE UNITED STATES BY TYPE OF PRACTICE, 2007
• LIFE CYCLE APPROACH
• INTERNATIONAL ISSUES AND TRENDS
  • TABLE 11 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2005, JAPAN AND AUSTRALIA (MILLIONS)
  • TABLE 12 ESTIMATED POPULATIONS OF FARM ANIMALS FOR 2004, BRAZIL (MILLIONS)

Chapter- 3: ANIMAL VACCINES

• OVERVIEW
• PRODUCT DESCRIPTION
• ACTIVE IMMUNITY
• PASSIVE IMMUNITY
• OTHER TYPES
• TARGET SPECIES AND PROVIDERS
  • TABLE 13 VACCINES BY TARGET SPECIES AND PROVIDERS
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
  • TABLE 13 (CONTINUED)
• COMPANION ANIMAL VACCINES
• BOEHRINGER INGELHEIM
• FORT DODGE
• HESKA
• MERIAL
• NOVARTIS
• SCHERING-PLOUGH
• FOOD ANIMAL VACCINES
• ALPHARMA
• BAYER
• BOEHRINGER INGELHEIM
• FORT DODGE
• INTERVET
• MERIAL
• NOVARTIS
• PFIZER
• SCHERING-PLOUGH
• Poultry
• Poultry (Continued)
• Poultry (Continued)
• Poultry (Continued)
• Cattle and Sheep
• Swine
• Rabies
• Fish
• MARKET ANALYSIS AND CONCLUSIONS
• MARKETS BY USE OR APPLICATION
  • TABLE 14 GLOBAL MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 1 GOBAL MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, 2006-2013 ($ MILLIONS)
• VACCINE MARKET BY TYPE
  • TABLE 15 ESTIMATED GLOBAL REVENUES FOR ANIMAL VACCINES BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 2 ESTIMATED GLOBAL REVENUES FOR ANIMAL VACCINES BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 16 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2007 (%/$ MILLIONS)
  • FIGURE 3 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
• Intervet
• Schering-Plough
• Fort Dodge
• Other Companies
  • TABLE 17 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2007 (%/$ MILLIONS)
  • FIGURE 4 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2007 (%)

Chapter- 4: ANIMAL PHARMACEUTICAL PRODUCTS

• OVERVIEW
• PRODUCT DESCRIPTION
• ALLERGY AND RESPIRATORY DRUGS
• TARGET SPECIES AND PROVIDERS
  • TABLE 18 ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES AND PROVIDERS
• ANTI-INFECTIVES AND ANTIFUNGALS
• Bayer
• Boehringer Ingelheim
• Elanco
• Esteve
• Fort Dodge
• ECO
• Novartis
• Pfizer
• Schering-Plough
• Target Species and Providers
  • TABLE 19 ANTI-INFECTIVES BY TARGET SPECIES AND PROVIDERS
  • TABLE 19 (CONTINUED)
  • TABLE 19 (CONTINUED)
• ANTI-INFLAMMATORIES AND ANALGESICS
• Bayer
• Boehringer Ingelheim
• Elanco
• Esteve
• Fort Dodge
• Bioniche
• Novartis
• Pfizer
• Schering-Plough
• Luitpold Animal Health
• Target Species and Providers
  • TABLE 20 ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES AND PROVIDERS
• METABOLIC DRUGS
• Target Species and Providers
  • TABLE 21 METABOLIC DRUGS BY TARGET SPECIES AND PROVIDERS
• PARASITICIDES
• Bayer
• Boehringer-Ingelheim
• Esteve
• Fort Dodge
• IDEXX
• ECO
• Merial
• Novartis
• Pfizer
• Schering-Plough
• Virbac
• Target Species and Providers
  • TABLE 22 PARASITICIDES BY TARGET SPECIES AND PROVIDERS
  • TABLE 22 (CONTINUED)
• OTHER PHARMACEUTICALS
• Esteve
• Merial
• Schering-Plough
• Dental
• Virbac
• Biopure
• Novartis
• Target Species and Providers
  • TABLE 23 OTHER PHARMACEUTICALS BY TARGET SPECIES AND PROVIDERS
• MARKET ANALYSIS AND CONCLUSIONS
• MARKETS BY USE OR APPLICATION
• Allergy and Respiratory Market
  • TABLE 24 GLOBAL MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 5 GLOBAL MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, 2006-2013 ($ MILLIONS)
• Anti-Infective Market
  • TABLE 25 GLOBAL MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 6 GLOBAL MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, 2006-2013 ($ MILLIONS)
• Anti-Inflammatory Market
  • TABLE 26 GLOBAL MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 7 GLOBAL MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE, 2006-2013 ($ MILLIONS)
• Metabolic Drug Market
  • TABLE 27 GLOBAL MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 8 GLOBAL MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, 2006-2013 ($ MILLIONS)
• Parasiticide Market
  • TABLE 28 GLOBAL MARKET ANALYSIS FOR PARASITICIDES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 9 GLOBAL MARKET ANALYSIS FOR PARASITICIDES BY USE, 2006-2013 ($ MILLIONS)
• Other Pharmaceuticals
  • TABLE 29 GLOBAL MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 10 GLOBAL MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, 2006-2013 ($ MILLIONS)
• TOTAL PHARMACEUTICALS
  • TABLE 30 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 11 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, 2006-2013 ($ MILLIONS)
• Summary-Pharmaceutical Markets
  • TABLE 31 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 12 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 32 DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2007 (%)
  • FIGURE 13 DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
  • TABLE 33 COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 14 COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2007 (%)

Chapter- 5: ANIMAL FEED ADDITIVES

• OVERVIEW
• PRODUCT DESCRIPTION
• AMINO ACIDS
• TARGET SPECIES AND PROVIDERS
  • TABLE 34 AMINO ACIDS BY TARGET SPECIES AND PROVIDERS
• MEDICINAL ADDITIVES
• Alpharma
• Elanco
• ECO
• Novartis
• Merial
• Pfizer
• Schering-Plough
• Boehringer Ingelheim
• Target Species and Providers
  • TABLE 35 MEDICINAL ADDITIVES BY TARGET SPECIES AND PROVIDERS
• NUTRITIONAL SUPPLEMENTS
• NUTRITIONAL SUPPLEMENTS (CONTINUED)
• TARGET SPECIES AND PROVIDERS
  • TABLE 36 NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES AND PROVIDERS
• VITAMINS AND MINERALS
• BEAPHAR
• ESTEVE
• ADISSEO
• MOSAIC (FORMERLY IMC GLOBAL)
• DSM NUTRITIONAL
• SCHERING-PLOUGH
• CHURCH & DWIGHT CO.
• VIRBAC
• TARGET SPECIES AND PROVIDERS
  • TABLE 37 VITAMINS AND MINERALS BY TARGET SPECIES AND PROVIDERS
  • TABLE 37 (CONTINUED)
• MARKET ANALYSIS AND CONCLUSION
• MARKETS BY USE OR APPLICATION
• Amino Acid Market
  • TABLE 38 GLOBAL MARKET ANALYSIS FOR AMINO ACIDS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 15 MARKET ANALYSIS FOR AMINO ACIDS BY USE, 2006-2013 ($ MILLIONS)
• Medicinal Feed Additive Market
  • TABLE 39 GLOBAL MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 16 GLOBAL MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, 2006-2013 ($ MILLIONS)
• Nutritional Supplement Market
  • TABLE 40 GLOBAL MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 17 GLOBAL MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, 2006-2013 ($ MILLIONS)
• Vitamin and Mineral Market
  • TABLE 41 GLOBAL MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 18 GLOBAL MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, 2006-2013 ($ MILLIONS)
• Total Feed Additive Market
  • TABLE 42 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 19 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, 2006-2013 ($ MILLIONS)
• FEED ADDITIVE MARKET BY TYPE
  • TABLE 43 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 20 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 44 DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2007 (%/$ MILLIONS)
  • FIGURE 21 DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
  • TABLE 45 COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 22 COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2007 (%)

Chapter- 6: ANIMAL DIAGNOSTICS

• OVERVIEW
• PRODUCT DESCRIPTION
• HESKA
• IDEXX
• SNAP
• PETCHEK
• DIASYSTEMS
• HERDCHEK
• FLOCKCHEK
• Guildhay and Svanovir
• SCHERING-PLOUGH
• SYNBIOTICS
• TARGET SPECIES AND PROVIDERS
  • TABLE 46 DIAGNOSTICS BY TARGET SPECIES AND PROVIDERS
  • TABLE 46 (CONTINUED)
• MARKET ANALYSIS AND CONCLUSION
• MARKETS BY USE OR APPLICATION
  • TABLE 47 GLOBAL MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 23 GLOBAL MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS BY USE, 2006-2013 ($ MILLIONS)
• DIAGNOSTIC MARKET BY TYPE
  • TABLE 48 ESTIMATED REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 24 ESTIMATED REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, 2006-2013 ($ MILLIONS)
• MARKETS BY GEOGRAPHICAL REGION
  • TABLE 49 DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2007 (%/$ MILLIONS)
  • FIGURE 25 DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2007 (%)
• COMPETITIVE SUMMARY
  • TABLE 50 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 26 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%)

Chapter- 7: MARKET SUMMARY

• TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTIC MARKET ANALYSIS
  • TABLE 51 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2013 ($ MILLIONS)
  • FIGURE 27 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY TYPE, THROUGH 2013 ($ MILLIONS)
  • TABLE 52 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, THROUGH 2013 ($ MILLIONS)
  • FIGURE 28 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, 2006-2013 ($ MILLIONS)
• INDUSTRY PARTICIPANTS BY TYPE
  • TABLE 53 MAJOR INDUSTRY PARTICIPANTS BY ANIMAL PRODUCT TYPE
• TOTAL COMPETITIVE ANALYSIS
  • TABLE 54 TOTAL COMPETITIVE MARKET SHARE FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2007 (%/$ MILLIONS)
  • FIGURE 29 TOTAL COMPETITIVE SUMMARY FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%)

Chapter- 8: COMPANY PROFILES

• COMPANY PROFILES
• ADISSEO FRANCE S.A.S
• ALPHARMA, INC.
• BASF ANIMAL NUTRITION (BASF AG)
• BAYER ANIMAL HEALTH
• BOEHRINGER INGELHEIM CORP.
• DSM NUTRITIONAL PRODUCTS
• ELANCO ANIMAL HEALTH
• EVONIK INDUSTRIES
• FORT DODGE ANIMAL HEALTH
• HESKA CORP.
• IDEXX LABORATORIES, INC.
• INTERVET INTERNATIONAL BV
• IVX ANIMAL HEALTH, INC.
• MERIAL ANIMAL HEALTH, LTD.
• MOSAIC
• NOVARTIS ANIMAL HEALTH, INC.
• NOVARTIS AG
• NOVUS INTERNATIONAL, INC.
• PFIZER ANIMAL HEALTH
• SCHERING-PLOUGH ANIMAL HEALTH
• SCHERING-PLOUGH CORP.
• VIRBAC SA
• VIRBAC SA (CONTINUED)
• APPENDIX I: LEADING MANUFACTURES AND AFFILIATED COMPANIES
• ACRUX, LTD.
• ADISSEO FRANCE S.A.S.
• AJINOMOTO CO., LTD.
• AKZO NOBEL N.V.
• ALPHARMA, INC.
• BASF AG
• BASF ANIMAL NUTRITION
• BAYER AG
• BAYER HEALTHCARE, LLC
• BEAPHAR B.V.
• BEN VENUE LABORATORIES, INC.
• BOEHRINGER INGELHEIM CHEMICALS, INC.
• BOEHRINGER INGELHEIM CORP.
• BOEHRINGER INGELHEIM GMBH
• BOEHRINGER INGELHEIM VETMEDICA, INC.
• DSM
• DSM NUTRITIONAL PRODUCTS
• ECO ANIMAL HEALTH
• ELANCO ANIMAL HEALTH
• ELI LILLY & CO.
• ESTEVE
• EVONIK DEGUSSA GMBH
• FORT DODGE ANIMAL HEALTH
• HESKA CORP.
• IDEXX LABORATORIES, INC.
• INTERVET INTERNATIONAL BV
• LUITPOLD ANIMAL HEALTH
• MOSAIC
• MERIAL ANIMAL HEALTH, LTD.
• NOVARTIS AG
• NOVARTIS ANIMAL HEALTH, INC.
• NOVARTIS ANIMAL VACCINES, INC.
• NOVUS INTERNATIONAL, INC.
• PFIZER ANIMAL HEALTH
• PFIZER, INC.
• ROXANE LABORATORIES, INC.
• SCHERING-PLOUGH ANIMAL HEALTH
• SCHERING-PLOUGH CORP.
• SYNBIOTICS CORP.
• VIRBAC S.A.
• WYETH

Chapter- 9: APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS

• AMERICAN ASSOCIATION OF FELINE PRACTITIONERS
• AMERICAN VETERINARY MEDICAL ASSOCIATION
• CANADIAN VETERINARY MEDICAL ASSOCIATION
• UNITED STATES DEPARTMENT OF AGRICULTURE
• UNITED STATES FOOD AND DRUG ADMINISTRATION